The VC-backed microrobotics startup Bionaut Labs has entered into a strategic collaboration with Candel Therapeutics. Candel (NSDQ:CADL) — a biopharma focused on oncolytic viral immunotherapies — will explore the use of Bionaut Labs’ miniature remote-controlled robots. Could the robots help deliver Candel’s oncolytic viral immunotherapy agents to certain brain tumors? Founded in 2016, Bionaut Labs…
Inside Candel Therapeutics adenovirus and HSV immunotherapy platforms
Candel Therapeutics (NSDQ:CADL) recently announced that it had entered a strategic collaboration with microrobotics startup Bionaut Labs (Los Angeles) to explore precision-targeted delivery of oncolytic viral immunotherapies. To learn more about the company, we reached out to Candel’s Dr. Paul Peter Tak, president and CEO of the company. Candel Therapeutics has two viral immunotherapy platforms,…